SELLAS Life Sciences Group, Inc.
Recent Filings
All 1,000 filings →| Form | Description | Date |
|---|---|---|
| SCHEDULE 13G/A | — | Mar 27, 2026 |
| S-3ASR | S-3ASR | Mar 20, 2026 |
| 8-K | 8-K | Mar 19, 2026 |
| 10-K | 10-K | Mar 19, 2026 |
| 8-K | FORM 8-K | Mar 11, 2026 |
| SCHEDULE 13G/A | — | Feb 17, 2026 |
| SCHEDULE 13G/A | — | Jan 30, 2026 |
| 4 | OWNERSHIP DOCUMENT | Jan 9, 2026 |
| 4 | OWNERSHIP DOCUMENT | Jan 9, 2026 |
| 4 | OWNERSHIP DOCUMENT | Jan 9, 2026 |
Insider Transactions
View all →| Insider | Title | Type | Shares | Owns After | Date |
|---|---|---|---|---|---|
| Kalin Katherine Bach | — | Purchase | 63,400 @ $1.59 | 104,400 | Nov 19, 2025 |
| VAN NOSTRAND ROBERT L | — | Purchase | 10,000 @ $1.48 | 20,400 | Jun 12, 2025 |
| Wasman Jane | — | Purchase | 20,000 @ $1.69 | 30,400 | May 30, 2025 |
| Kalin Katherine Bach | — | Purchase | 20,000 @ $1.80 | 41,000 | May 22, 2025 |
| Burns John Thomas | CFO | Award / Grant | 81,300 | 299,062 | Jan 10, 2025 |
| Stergiou Angelos M. | President and CEO | Award / Grant | 257,000 | 615,132 | Jan 10, 2025 |
| SCHEINBERG DAVID A | — | Award / Grant | 12,500 | 23,082 | Jan 10, 2025 |
| Wasman Jane | — | Award / Grant | 12,500 | 22,900 | Jan 10, 2025 |
| VAN NOSTRAND ROBERT L | — | Award / Grant | 12,500 | 22,900 | Jan 10, 2025 |
| Kalin Katherine Bach | — | Award / Grant | 12,500 | 21,000 | Jan 10, 2025 |